Back
NeoGenomics, Inc. Vs. Panbela Therapeutics, Inc. Industry Stock Comparison
Buy
57
NEO
NeoGenomics, Inc.
Last Price:
$12.30
Seasonality Move:
40.74%
Sell
5
PBLA
Panbela Therapeutics, Inc.
Last Price:
$0.0100
Seasonality Move:
-13.55%
Buy
57
NeoGenomics, Inc. (NEO)
is a Buy
Is NeoGenomics, Inc. a Buy, Sell or Hold?
-
The current NeoGenomics, Inc. [NEO] share price is $12.28. The Score for NEO is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
NEO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
5
Panbela Therapeutics, Inc. (PBLA)
is a Sell
Is Panbela Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Panbela Therapeutics, Inc. [PBLA] share price is $0.0011. The Score for PBLA is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
-
PBLA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
NEO Stock Price Chart
What is NeoGenomics, Inc.'s stock price today?
-
The NeoGenomics, Inc. share price today is $12.28Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NEO is experiencing slight selling pressure.
PBLA Stock Price Chart
What is Panbela Therapeutics, Inc.'s stock price today?
-
The Panbela Therapeutics, Inc. share price today is $0.0011Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PBLA is experiencing selling pressure, which indicates risk of future bearish movement.
NEO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.35 | Buy |
| Relative Strength Index (14 RSI): | 63.65 | Buy |
| Chaikin Money Flow: | -297905 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.54 - 12.28) | Buy |
| Bollinger Bands (100): | (7.41 - 11.37) | Buy |
PBLA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 36.32 | Sell |
| Chaikin Money Flow: | -105995 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.0022 - 0.0222) | Sell |
| Bollinger Bands (100): | (-0.0083 - 0.1117) | Sell |
NEO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.03 | Buy |
| 20-day SMA: | 11.98 | Buy |
| 50-day SMA: | 11.07 | Buy |
| 200-day SMA: | 8.65 | Buy |
| 8-day EMA: | 12.13 | Buy |
| 20-day EMA: | 11.86 | Buy |
| 50-day EMA: | 11.03 | Buy |
| 200-day EMA: | 10.01 | Buy |
PBLA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.01 | Sell |
| 20-day SMA: | 0.01 | Sell |
| 50-day SMA: | 0.01 | Sell |
| 200-day SMA: | 0.16 | Sell |
| 8-day EMA: | 0 | Sell |
| 20-day EMA: | 0 | Buy |
| 50-day EMA: | 0 | Buy |
| 200-day EMA: | 0 | Buy |
NeoGenomics, Inc. Earnings Growth & NEO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.08 per share.
Panbela Therapeutics, Inc. Earnings Growth & PBLA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.71 per share, and an increase next year of $0.30 per share.
NeoGenomics, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Panbela Therapeutics, Inc. Technical Analysis
| Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||